Genes and immune cells predict immunotherapy success in bladder cancer

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of the bladder have been identified and validated by researchers at Mount Sinai. In a study published in Clinical Cancer Research, the team uncovered gene signatures representing adaptive immunity and pro-tumorigenic inflammation that were responsible for sensitivity or resistance to immune checkpoint inhibitors, drugs that help the body's immune system recognize and attack cancerous cells.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news